Renal Cell Carcinoma: Developing Drugs and Biologics for Adjuvant Treatment: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 27, 2022
June 28, 2022
db30c852-ed7b-4054-8906-3aadd3851179
Related Documents
Premenopausal Women with Breast Cancer: Developing Drugs for Treatment: Guidance for Industry
Guidance DocumentJune 17, 2021Office of the Commissioner
Bladder Cancer: Developing Drugs and Biologics for Adjuvant Treatment: Guidance for Industry
Guidance DocumentJune 28, 2022Office of the Commissioner
Male Breast Cancer: Developing Drugs for Treatment: Guidance for Industry
Guidance DocumentAugust 12, 2020Office of the Commissioner
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.